Preimplantation genetic testing for aneuploidy: helpful but not a first choice

Purpose This retrospective cohort study aimed to assess and compare the outcomes between cumulative live birth of patients with and without PGT-A and also between prior unsuccessful IVF cycles and PGT-A cycles among patients who experienced IVF but without live birth delivery, and to clarify the eff...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of assisted reproduction and genetics 2023-01, Vol.40 (1), p.161-168
Hauptverfasser: Ohishi, Sachiko, Otani, Tetsuo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 168
container_issue 1
container_start_page 161
container_title Journal of assisted reproduction and genetics
container_volume 40
creator Ohishi, Sachiko
Otani, Tetsuo
description Purpose This retrospective cohort study aimed to assess and compare the outcomes between cumulative live birth of patients with and without PGT-A and also between prior unsuccessful IVF cycles and PGT-A cycles among patients who experienced IVF but without live birth delivery, and to clarify the effective usage of PGT-A as an in vitro fertilization (IVF) add-on. Methods A total of 2113 females undergoing IVF with at least one blastocyst were reviewed. Patients in the PGT-A and non-PGT-A groups were further categorized into first-time IVF and prior unsuccessful IVF groups (previous IVF experience but without live birth delivery). Results In the PGT-A group, there were additional oocyte retrieval cycles, fewer transfer cycles per patient, higher clinical pregnancy rates per embryo transfer, and lower miscarriage rates per clinical pregnancy as compared to the non-PGT-A group, all showing significant differences. However, the first-time IVF group with PGT-A had a significantly longer duration from the first oocyte retrieval to the first live birth delivery (LBD) and a significantly lower LBD rate per patient than the non-PGT-A group. The cumulative probability for a first LBD with PGT-A was inferior in the first-time IVF group for women 
doi_str_mv 10.1007/s10815-022-02683-x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9840739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2765406477</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-6197c25e7866395e84bbbe5f87245b2972859e3e9fae4c943ad26c9853d766733</originalsourceid><addsrcrecordid>eNp9UU1PHDEMjRCoUOAPcECROA_NJJOvHpAQamklBD205yiT9ewGzSbTJIPYf0_oUmgvHCxb8vN7th9CJy05bwmRn3JLVMsbQmkNoVjzuIMOWi5ZIxkju7UmXDWkE2offcz5nhCiFWUf0D4TnCjC2AG6_ZHAr6fRhmKLjwEvIUDxDhfIxYclHmLCNsA8jdEvNp_xCsZpmEfczwWHWLDFg0-5YLeK3sER2hvsmOH4JR-iX1-__Lz61tzcXX-_urxpHNOyNKLV0lEOUgnBNAfV9X0PfFCSdrynWlLFNTDQg4XO6Y7ZBRVOK84WUoh63SG62PJOc7-GhYNQkh3NlPzapo2J1pv_O8GvzDI-GK06IpmuBGcvBCn-nuut5j7OKdSdDZWCd0R0UlYU3aJcijknGF4VWmKePTBbD0z1wPzxwDzWodN_d3sd-fv0CmBbQK6tsIT0pv0O7ROn3JNr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2765406477</pqid></control><display><type>article</type><title>Preimplantation genetic testing for aneuploidy: helpful but not a first choice</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Ohishi, Sachiko ; Otani, Tetsuo</creator><creatorcontrib>Ohishi, Sachiko ; Otani, Tetsuo</creatorcontrib><description>Purpose This retrospective cohort study aimed to assess and compare the outcomes between cumulative live birth of patients with and without PGT-A and also between prior unsuccessful IVF cycles and PGT-A cycles among patients who experienced IVF but without live birth delivery, and to clarify the effective usage of PGT-A as an in vitro fertilization (IVF) add-on. Methods A total of 2113 females undergoing IVF with at least one blastocyst were reviewed. Patients in the PGT-A and non-PGT-A groups were further categorized into first-time IVF and prior unsuccessful IVF groups (previous IVF experience but without live birth delivery). Results In the PGT-A group, there were additional oocyte retrieval cycles, fewer transfer cycles per patient, higher clinical pregnancy rates per embryo transfer, and lower miscarriage rates per clinical pregnancy as compared to the non-PGT-A group, all showing significant differences. However, the first-time IVF group with PGT-A had a significantly longer duration from the first oocyte retrieval to the first live birth delivery (LBD) and a significantly lower LBD rate per patient than the non-PGT-A group. The cumulative probability for a first LBD with PGT-A was inferior in the first-time IVF group for women &lt; 35 years, marginally superior in the prior unsuccessful IVF group of women aged 38–40 years, and similar for other groups. Conclusion PGT-A should not be recommended to all patients; however, if the first IVF treatment failed, PGT-A may reduce the patient’s burden regardless of age.</description><identifier>ISSN: 1058-0468</identifier><identifier>EISSN: 1573-7330</identifier><identifier>DOI: 10.1007/s10815-022-02683-x</identifier><identifier>PMID: 36508033</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aneuploidy ; Assisted Reproduction Technologies ; Birth ; Embryo transfer ; Female ; Fertilization in Vitro ; Genetic screening ; Genetic Testing ; Gynecology ; Human Genetics ; Humans ; In vitro fertilization ; Medicine ; Medicine &amp; Public Health ; Patients ; Pregnancy ; Pregnancy Rate ; Preimplantation Diagnosis ; Reproductive Medicine ; Retrospective Studies</subject><ispartof>Journal of assisted reproduction and genetics, 2023-01, Vol.40 (1), p.161-168</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-6197c25e7866395e84bbbe5f87245b2972859e3e9fae4c943ad26c9853d766733</citedby><cites>FETCH-LOGICAL-c397t-6197c25e7866395e84bbbe5f87245b2972859e3e9fae4c943ad26c9853d766733</cites><orcidid>0000-0003-1724-8072 ; 0000-0002-2256-905X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840739/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840739/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36508033$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohishi, Sachiko</creatorcontrib><creatorcontrib>Otani, Tetsuo</creatorcontrib><title>Preimplantation genetic testing for aneuploidy: helpful but not a first choice</title><title>Journal of assisted reproduction and genetics</title><addtitle>J Assist Reprod Genet</addtitle><addtitle>J Assist Reprod Genet</addtitle><description>Purpose This retrospective cohort study aimed to assess and compare the outcomes between cumulative live birth of patients with and without PGT-A and also between prior unsuccessful IVF cycles and PGT-A cycles among patients who experienced IVF but without live birth delivery, and to clarify the effective usage of PGT-A as an in vitro fertilization (IVF) add-on. Methods A total of 2113 females undergoing IVF with at least one blastocyst were reviewed. Patients in the PGT-A and non-PGT-A groups were further categorized into first-time IVF and prior unsuccessful IVF groups (previous IVF experience but without live birth delivery). Results In the PGT-A group, there were additional oocyte retrieval cycles, fewer transfer cycles per patient, higher clinical pregnancy rates per embryo transfer, and lower miscarriage rates per clinical pregnancy as compared to the non-PGT-A group, all showing significant differences. However, the first-time IVF group with PGT-A had a significantly longer duration from the first oocyte retrieval to the first live birth delivery (LBD) and a significantly lower LBD rate per patient than the non-PGT-A group. The cumulative probability for a first LBD with PGT-A was inferior in the first-time IVF group for women &lt; 35 years, marginally superior in the prior unsuccessful IVF group of women aged 38–40 years, and similar for other groups. Conclusion PGT-A should not be recommended to all patients; however, if the first IVF treatment failed, PGT-A may reduce the patient’s burden regardless of age.</description><subject>Aneuploidy</subject><subject>Assisted Reproduction Technologies</subject><subject>Birth</subject><subject>Embryo transfer</subject><subject>Female</subject><subject>Fertilization in Vitro</subject><subject>Genetic screening</subject><subject>Genetic Testing</subject><subject>Gynecology</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>In vitro fertilization</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Patients</subject><subject>Pregnancy</subject><subject>Pregnancy Rate</subject><subject>Preimplantation Diagnosis</subject><subject>Reproductive Medicine</subject><subject>Retrospective Studies</subject><issn>1058-0468</issn><issn>1573-7330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9UU1PHDEMjRCoUOAPcECROA_NJJOvHpAQamklBD205yiT9ewGzSbTJIPYf0_oUmgvHCxb8vN7th9CJy05bwmRn3JLVMsbQmkNoVjzuIMOWi5ZIxkju7UmXDWkE2offcz5nhCiFWUf0D4TnCjC2AG6_ZHAr6fRhmKLjwEvIUDxDhfIxYclHmLCNsA8jdEvNp_xCsZpmEfczwWHWLDFg0-5YLeK3sER2hvsmOH4JR-iX1-__Lz61tzcXX-_urxpHNOyNKLV0lEOUgnBNAfV9X0PfFCSdrynWlLFNTDQg4XO6Y7ZBRVOK84WUoh63SG62PJOc7-GhYNQkh3NlPzapo2J1pv_O8GvzDI-GK06IpmuBGcvBCn-nuut5j7OKdSdDZWCd0R0UlYU3aJcijknGF4VWmKePTBbD0z1wPzxwDzWodN_d3sd-fv0CmBbQK6tsIT0pv0O7ROn3JNr</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Ohishi, Sachiko</creator><creator>Otani, Tetsuo</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1724-8072</orcidid><orcidid>https://orcid.org/0000-0002-2256-905X</orcidid></search><sort><creationdate>20230101</creationdate><title>Preimplantation genetic testing for aneuploidy: helpful but not a first choice</title><author>Ohishi, Sachiko ; Otani, Tetsuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-6197c25e7866395e84bbbe5f87245b2972859e3e9fae4c943ad26c9853d766733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aneuploidy</topic><topic>Assisted Reproduction Technologies</topic><topic>Birth</topic><topic>Embryo transfer</topic><topic>Female</topic><topic>Fertilization in Vitro</topic><topic>Genetic screening</topic><topic>Genetic Testing</topic><topic>Gynecology</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>In vitro fertilization</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Patients</topic><topic>Pregnancy</topic><topic>Pregnancy Rate</topic><topic>Preimplantation Diagnosis</topic><topic>Reproductive Medicine</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohishi, Sachiko</creatorcontrib><creatorcontrib>Otani, Tetsuo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of assisted reproduction and genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohishi, Sachiko</au><au>Otani, Tetsuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preimplantation genetic testing for aneuploidy: helpful but not a first choice</atitle><jtitle>Journal of assisted reproduction and genetics</jtitle><stitle>J Assist Reprod Genet</stitle><addtitle>J Assist Reprod Genet</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>40</volume><issue>1</issue><spage>161</spage><epage>168</epage><pages>161-168</pages><issn>1058-0468</issn><eissn>1573-7330</eissn><abstract>Purpose This retrospective cohort study aimed to assess and compare the outcomes between cumulative live birth of patients with and without PGT-A and also between prior unsuccessful IVF cycles and PGT-A cycles among patients who experienced IVF but without live birth delivery, and to clarify the effective usage of PGT-A as an in vitro fertilization (IVF) add-on. Methods A total of 2113 females undergoing IVF with at least one blastocyst were reviewed. Patients in the PGT-A and non-PGT-A groups were further categorized into first-time IVF and prior unsuccessful IVF groups (previous IVF experience but without live birth delivery). Results In the PGT-A group, there were additional oocyte retrieval cycles, fewer transfer cycles per patient, higher clinical pregnancy rates per embryo transfer, and lower miscarriage rates per clinical pregnancy as compared to the non-PGT-A group, all showing significant differences. However, the first-time IVF group with PGT-A had a significantly longer duration from the first oocyte retrieval to the first live birth delivery (LBD) and a significantly lower LBD rate per patient than the non-PGT-A group. The cumulative probability for a first LBD with PGT-A was inferior in the first-time IVF group for women &lt; 35 years, marginally superior in the prior unsuccessful IVF group of women aged 38–40 years, and similar for other groups. Conclusion PGT-A should not be recommended to all patients; however, if the first IVF treatment failed, PGT-A may reduce the patient’s burden regardless of age.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36508033</pmid><doi>10.1007/s10815-022-02683-x</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1724-8072</orcidid><orcidid>https://orcid.org/0000-0002-2256-905X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-0468
ispartof Journal of assisted reproduction and genetics, 2023-01, Vol.40 (1), p.161-168
issn 1058-0468
1573-7330
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9840739
source MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Aneuploidy
Assisted Reproduction Technologies
Birth
Embryo transfer
Female
Fertilization in Vitro
Genetic screening
Genetic Testing
Gynecology
Human Genetics
Humans
In vitro fertilization
Medicine
Medicine & Public Health
Patients
Pregnancy
Pregnancy Rate
Preimplantation Diagnosis
Reproductive Medicine
Retrospective Studies
title Preimplantation genetic testing for aneuploidy: helpful but not a first choice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A28%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preimplantation%20genetic%20testing%20for%20aneuploidy:%20helpful%20but%20not%20a%20first%20choice&rft.jtitle=Journal%20of%20assisted%20reproduction%20and%20genetics&rft.au=Ohishi,%20Sachiko&rft.date=2023-01-01&rft.volume=40&rft.issue=1&rft.spage=161&rft.epage=168&rft.pages=161-168&rft.issn=1058-0468&rft.eissn=1573-7330&rft_id=info:doi/10.1007/s10815-022-02683-x&rft_dat=%3Cproquest_pubme%3E2765406477%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2765406477&rft_id=info:pmid/36508033&rfr_iscdi=true